MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Akerna Corp. Income Statement 2011-2026 | KERN
Annual Income Statement Akerna Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
263 M | 215 M | 918 K | 25.6 M | 75 M | 70.4 M | 75.8 M | - | - | - | - | - | - | - |
Shares |
41.9 M | 34.3 M | 146 K | 25.6 M | 11.9 M | 6.05 M | 7.43 M | - | - | - | - | - | - | - |
Historical Prices |
6.27 | 6.27 | 6.27 | 1.37 | 5.82 | 8.12 | 10.1 | - | - | - | - | - | - | - |
Net Income |
-21.3 M | -28.6 M | -79.1 M | -31.3 M | -15.5 M | -12.3 M | -30 K | - | - | - | - | - | - | - |
Revenue |
20.5 M | 21.9 M | 10.5 M | 20.7 M | 12.6 M | 10.9 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
15.8 M | 13.5 M | 4.91 M | 8.12 M | 4.39 M | 4.63 M | 4.36 M | - | - | - | - | - | - | - |
Gross Profit |
- | - | 5.55 M | 12.6 M | 6.36 M | 6.29 M | - | - | - | - | - | - | - | - |
Operating Income |
-17.7 M | -19.2 M | -43.1 M | -33.4 M | -17.3 M | -12.5 M | -2.46 M | - | - | - | - | - | - | - |
Interest Expense |
- | 446 K | -221 K | 186 K | 3.73 K | -91.2 K | -5.84 K | - | - | - | - | - | - | - |
EBITDA |
-6.57 M | -4.22 M | -35.2 M | -27.6 M | -11.7 M | -12.4 M | -898 K | - | - | - | - | - | - | - |
Operating Expenses |
- | - | 48.6 M | 45.9 M | 19.4 M | 18.7 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
11.3 M | 4.76 M | 8.02 M | 1.1 | 7.07 M | 13.1 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Akerna Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
899 M | 76 M | 70.6 M | 53 M | 892 M | 38.9 M | 32.4 M | 25.1 M | 14.5 M | 14.4 M | 5.77 M | 4.6 M | 3.88 M | 31 M | 31.6 M | 1.55 M | 26.4 M | 24.5 M | 22.2 M | 19.9 M | 13.9 M | 13.2 M | 14.1 M | 11 M | 10.9 M | 10.9 M | 10.9 M | 6.02 M | 5.49 M | 4.92 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
3.48 M | -5.26 M | -6.28 M | - | -576 K | -4.01 M | -11.7 M | - | -8.09 M | -2.62 M | -2.47 M | - | -2.3 M | -29.6 M | -22 M | 400 K | -1.55 M | -6.11 M | -6.46 M | - | -3.98 M | -5.31 M | -16.2 M | -4.34 M | -2.33 M | -4.34 M | -2.85 M | -2.39 M | -1.7 M | - | 364 K | -992 K | -1.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
64.2 M | 1.38 M | 1.56 M | - | 11.6 M | 5.52 M | 7.49 M | - | 5.48 M | 5.28 M | 2.6 M | - | 3.06 M | 3.49 M | 4.25 M | - | 5.14 M | 4.91 M | 4.01 M | - | 3.71 M | 3 M | 3.71 M | 3.31 M | 3.19 M | 6.5 M | 3.19 M | 2.57 M | 2.3 M | - | 2.32 M | 2.86 M | 2.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
28.3 M | 1.61 M | 2.05 M | - | 11.1 M | 3.8 M | 4.84 M | - | 3.98 M | 2.82 M | 1.05 M | - | 1.48 M | 1.18 M | 1.52 M | - | 1.97 M | 1.91 M | 1.45 M | - | 1.74 M | 1.82 M | 1.74 M | 1.62 M | 1.38 M | 1.64 M | 1.4 M | 1.32 M | 1.06 M | - | 818 K | 1.15 M | 1.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | 1.11 M | 1.32 M | 1.55 M | - | 1.59 M | 2.31 M | 2.72 M | - | 3.16 M | 2.99 M | 2.56 M | - | 1.97 M | 1.19 M | 1.97 M | 1.69 M | 1.81 M | 1.67 M | 1.8 M | 1.25 M | 1.24 M | - | 1.5 M | 1.71 M | 1.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
7.2 M | -2.23 M | -5.47 M | - | -10.2 M | -5.87 M | -1.56 M | - | -9.2 M | -2.68 M | -1.93 M | - | -3.71 M | -20.2 M | -19.9 M | - | -3.72 M | -6.05 M | -3.51 M | - | -5.52 M | -6.18 M | -5.52 M | -4.39 M | -2.4 M | -7.31 M | -2.92 M | -2.45 M | -1.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | 283 K | 282 K | - | - | 15.9 K | 17.8 K | - | - | - | - | - | - | 243 | 243 | 776 K | - | -124 | -124 | -124 | 157 | -73.4 K | -130 | -287 | 26.4 K | -17.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
22.4 M | -1.72 M | -4.4 M | - | -5.88 M | -2.57 M | 1.69 M | - | -5.13 M | 1.17 M | -1.61 M | - | -2.16 M | -18.7 M | -17.9 M | - | -2.48 M | -3.68 M | -2.45 M | - | -4.35 M | -4.97 M | -5.52 M | -4.39 M | -2.38 M | -7.31 M | -2.92 M | -2.45 M | -1.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | 3.69 M | 3.08 M | 3.48 M | - | 5.3 M | 22.5 M | 22.6 M | - | 6.88 M | 9.04 M | 6.07 M | - | 7.5 M | 7.37 M | 7.5 M | 6.06 M | 4.21 M | 10.8 M | 4.71 M | 3.7 M | 2.95 M | - | 1.12 M | 2.69 M | 2.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
8.05 M | 1.65 M | 3 M | - | 4.81 M | 3.83 M | 2.46 M | - | 804 K | 1.09 M | 1.56 M | - | 1.83 M | 100 K | 1.92 M | - | 2.08 M | 4.38 M | 1.85 M | - | 2.47 M | 3.13 M | 2.47 M | 4.88 M | 1.74 M | 4.8 M | 3.58 M | 2.63 M | 2.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Akerna Corp. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Health information services industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
- | - | $ 27.9 B |  USA |
 |
Accolade
ACCD
|
- | 0.29 % | $ 206 M | USA |
 |
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
- | - | $ 2.94 B | USA |
 |
iCAD
ICAD
|
- | - | $ 102 M | USA |
 |
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | USA |
 |
HealthStream
HSTM
|
$ 22.03 | 1.52 % | $ 669 M | USA |
 |
Premier
PINC
|
- | - | $ 2.33 B | USA |
 |
R1 RCM
RCM
|
- | - | $ 3.81 B | USA |
 |
American Well Corporation
AMWL
|
$ 5.56 | 7.96 % | $ 89.2 M | USA |
 |
Evolent Health
EVH
|
$ 3.55 | 1.28 % | $ 333 M | USA |
 |
HealthEquity
HQY
|
$ 81.45 | 1.27 % | $ 6.97 B | USA |
 |
Change Healthcare
CHNG
|
- | - | $ 9.03 B | USA |
 |
Omnicell
OMCL
|
$ 41.51 | 1.73 % | $ 1.91 B | USA |
 |
GoodRx Holdings
GDRX
|
$ 2.19 | 5.8 % | $ 845 M | USA |
 |
Progyny
PGNY
|
$ 17.95 | 2.43 % | $ 1.54 B | USA |
 |
Health Catalyst
HCAT
|
$ 1.94 | 12.79 % | $ 117 M | USA |
 |
Schrödinger
SDGR
|
$ 13.17 | 5.32 % | $ 967 M | USA |
 |
Teladoc Health
TDOC
|
$ 5.2 | 1.76 % | $ 916 M | USA |
 |
So-Young International
SY
|
$ 2.89 | 3.96 % | $ 229 M |  China |
 |
10x Genomics
TXG
|
$ 22.46 | -0.73 % | $ 2.63 B | USA |
 |
SCWorx Corp.
WORX
|
$ 0.14 | -19.22 % | $ 204 K | USA |
 |
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | USA |
 |
OptimizeRx Corporation
OPRX
|
$ 7.94 | 8.47 % | $ 136 M | USA |
 |
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | USA |
 |
Veeva Systems
VEEV
|
$ 188.53 | 1.38 % | $ 30.3 B | USA |
 |
Phreesia
PHR
|
$ 12.67 | 2.34 % | $ 691 M | USA |
 |
Zhongchao
ZCMD
|
$ 1.69 | -1.98 % | $ 8.8 M | China |
 |
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | USA |